You just read:

Ionis Pharmaceuticals Reports Positive Data from Phase 2 Study of IONIS-GCGR Rx in Patients with Type 2 Diabetes

News provided by

Ionis Pharmaceuticals, Inc.

Jan 04, 2017, 07:00 ET